4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-17-035399
Options or other derivatives
- Senior VP - CMO acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Sheridan William P · Senior VP - CMO
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2017-12-20 | Grant or award : show line 1 in the form Emp. Stock Option (Right to Buy) | +100,000 | $5.04 | 2027-12-20 | 100,000 | 100,000 | D |
Loading xslF345X03/form4.xml…